SUNNYVALE, CA -- (Marketwire) -- 03/03/11 -- Juniper Networks (NYSE: JNPR) unveiled the industry's first Converged Supercore switch with unprecedented scalability of up to 3800 Terabits. By merging the core packet and optical network layers, Juniper has dramatically reduced complexity in the service provider network while improving the economics of supporting the increasingly unpredictable traffic patterns driven by the rapid growth of mobile, video and cloud computing applications.
Powered by the new purpose-built Junos Express chipset and the proven reliability ... read more
Orexigen® Therapeutics, Inc. (Nasdaq: OREX), a biopharmaceutical company focused on the treatment of obesity, will announce fourth quarter and year ended December 31, 2010 financial results on Thursday, March 10, 2011 after the markets close. The announcement will be followed by a live webcast and conference call at 5:00 p.m. Eastern time.
Orexigen management will host the call and webcast to discuss financial results and recent business highlights. The live call may be accessed by phone by calling (866) 788-0543 ... read more
U.S. Home Systems, Inc. (Nasdaq: USHS) today announced the availability of an online kitchen designer tool (http://www.cabinetrefacing.com) to help homeowners update kitchens with cabinet refacing and other pre-set options. The site is sponsored by US Remodelers, an operating subsidiary of U.S. Home Systems.
US Remodeler's site will guide remodelers, meeting specific requirements, with a variety of cabinet styles, colors and wood selections as well as optional countertop selections. In addition, the website allows users to schedule free in-home estimates, contains information ... read more
TechPrecision Corporation (OTC Bulletin Board: TPCS) ("TechPrecision", or "the Company"), a leading manufacturer of large-scale, high-precision machined metal fabrications with customers in the alternative energy, medical, nuclear, defense, aerospace and other commercial industries, today announced that Mr. James Molinaro, the Company's chief executive officer, will present at the ROTH 23rd Annual OC Growth Stock Conference at 8 a.m. (PT), on March 16, 2011, Track 5. The conference will be held March 13-16, 2011 at The Ritz Carlton, 1 Ritz Carlton ... read more
Gerber Scientific, Inc. (NYSE: GRB) today reported revenue and operating results for its fiscal 2011 third quarter ended January 31, 2011.
Summary of Results from Continuing Operations for FY 2011 Third Quarter versus FY 2010 Third Quarter
-- Reported revenue increased 12.8% to $112.0 million, or up 14.7% on a
constant currency basis;
-- Gross profit increased $7.3 million to $37.1 million, reflecting higher
... read more
BOTHELL, WA -- (Marketwire) -- 03/03/11 -- AVI BioPharma, Inc. (NASDAQ: AVII), a developer of RNA-based therapeutics, will report fourth quarter and full year 2010 financial results after the NASDAQ Global Market closes on Thursday, March 10, 2011. Subsequently, at 5:00 p.m. Eastern time (2:00 p.m. Pacific time), Chris Garabedian, AVI's president and CEO, will host a conference call to discuss fourth quarter and full year 2010 financial results and to provide a corporate update.
The conference call may be ... read more
MEDFORD, MA -- (Marketwire) -- 03/03/11 -- Hepregen Corporation, a leading provider of bioengineered solutions that increase success in drug development in order to improve patient safety, will launch its proprietary technology platform, HepatoPac, at the SOT 50th Anniversary Annual Meeting and ToxExpo in Washington, D.C. on March 7, 2011.
HepatoPac is a microliver platform for use in clearance predictions, metabolite profiling, transporter studies, and toxicity determination during the drug development process. Hepregen's HepatoPac products will be available through ... read more
MEDFORD, NY -- (Marketwire) -- 03/03/11 -- Chembio Diagnostics, Inc. (OTCQB: CEMI)
(PINKSHEETS: CEMI), which develops, manufactures, markets and licenses
point-of-care diagnostic tests, reported record revenues and earnings for
the year ended December 31, 2010. Total revenues were $16.7 million for the
year ended December 31, 2010, which compares to total revenues of $13.8
million for the year ended December 31, 2009, a 20.8% increase. The Company
recorded net income of approximately $2.51 million, or $0.04 per share, for
the year ended December 31, 2010, compared ... read more
SAN JOSE, CA -- (Marketwire) -- 03/03/11 -- Brocade® (NASDAQ: BRCD) company executives will present at the following financial conferences. All presentations will be available on a live Webcast via the Internet at http://www.brcd.com.
Dave Stevens, Chief Technology Officer, will present at the Signal Hill Technology Conference on Wednesday, March 9, 2011 at the Peninsula Hotel, New York, NY from 4:00 p.m. to 4:25 p.m. ET.
Mr. Stevens will also present at the Wedbush Morgan 2011 Technology, Media & Telecommunications ... read more
Cloudforce 2011 -- iContact was honored by salesforce.com customers with one of the AppExchange Best of '10 Awards. In receiving this customer choice award for Mass E-mails, iContact joined all the winners in receiving recognition for their ability to take customer success to new levels in satisfaction and application excellence. Built using the Force.com platform, iContact can be found on the AppExchange, the world's most-popular marketplace for business apps, at http://www.salesforce.com/appexchange/.
iContact, the #1 private email marketing service provider, allows individuals ... read more
MELBOURNE, Fla. and WASHINGTON, March 3, 2011 /PRNewswire/ --
-- Harris antennas provide satellites with flexibility to adapt to
ever-changing usage patterns
-- Award further positions Harris as leading antenna provider in
fast-growing Ka-band satellite market
-- Antenna design reflects Harris' 30+ years experience in space-borne
antenna ... read more
The launch of a new, non-invasive test for the identification of Turner syndrome (TS) was announced today by JS Genetics. The test, XCAT-TS, is a simple cheek swab that identifies girls with Turner syndrome. Until now, Turner syndrome could only be diagnosed with a Karyotype, an invasive test that requires blood from the patient. The results of the XCAT-TS validation study were published in the February 2011 issue of Journal of Clinical Endocrinology & Metabolism.
Turner syndrome, which affects females, ... read more
Optimer Pharmaceuticals, Inc. (Nasdaq: OPTR) today announced it expects to report fourth quarter and full year 2010 financial results after the NASDAQ Global Market closes on Thursday, March 10, 2011. The Company also expects to host a conference call that day at 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time) to discuss the financial results and highlights for the fourth quarter and full year 2010, as well as provide a corporate update.
The conference call may be ... read more
ECR Booth #313/Expo C - Varian Medical Systems, Inc., X-Ray Products, will be showcasing a comprehensive imaging portfolio of PaxScan® digital image detectors and X-ray tubes for fluoroscopy, angiography, cardiology and cone-beam CT imaging at the European Congress of Radiology (ECR) annual meeting in Vienna, Austria this week.
"Our exhibit reflects our commitment to the industry's demands for technically advanced X-ray tube and flat panel solutions," said Steve Kimmel, vice president of Sales and Marketing for Varian X-Ray Products. ... read more
Medstreaming's Medical Office EMR has received Complete EHR Ambulatory certification, validating the EMR software and enabling providers to demonstrate stage 1 meaningful use and qualify for funding under the American Recovery and Reinvestment Act (ARRA). Tested and certified under the Drummond Group's Electronic Health Records Office of the National Coordinator Authorized Testing and Certification Body (ONC-ATCB) program, Medstreaming's EMR software is stage 1-compliant for 2011/2012, in accordance with the criteria adopted by the Secretary of Health and Human Services. ... read more
Ventus Medical, Inc. a privately-held medical device company dedicated to providing novel products to treat sleep-disordered breathing, today announced that it has received CE Mark for its Provent® Sleep Apnea Therapy.
"We are pleased to accomplish this important regulatory milestone. Receiving CE Mark for Provent Therapy will facilitate our international commercialization strategy and allow us to launch this product in selected countries over the next several months," said Peter Wyles, president and chief executive officer of ... read more
Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN), Eli Lilly and Company (NYSE: LLY) and Alkermes, Inc. (Nasdaq: ALKS) today announced top-line results from DURATION-6, a head-to-head study designed to compare weekly BYDUREON(TM) (exenatide extended-release for injectable suspension), an investigational type 2 diabetes therapy, to daily Victoza® (liraglutide (rDNA origin) injection). Both drugs are members of the class of type 2 diabetes medications known as glucagon-like peptide-1 (GLP-1) receptor agonists.
This open-label 26-week, multicenter clinical study compared BYDUREON (2 mg weekly) to Victoza administered ... read more
Insmed Incorporated (Nasdaq: INSM), a biopharmaceutical company, announced today that the Pediatric Committee of the European Medicines Agency (EMA) has issued a positive opinion on the Company's Pediatric Investigation Plan (PIP) for ARIKACE(TM) (liposomal amikacin for inhalation), Insmed's Phase 3-ready compound for cystic fibrosis (CF) Pseudomonas and non-TB mycobacteria (NTM) lung infections. The PIP covers children from birth to 18 years of age with cystic fibrosis that suffer from Pseudomonas lung infections.
An accepted PIP is a pre-requisite for European ... read more
Cempra Pharmaceuticals today announced the appointment of David Oldach, M.D. as vice president, clinical research as well as announcing an expansion of its clinical development team to manage the company's leading clinical programs, solithromycin and TAKSTA through advanced clinical development. The four appointments have significant anti-infective clinical development experience.
Solithromycin is Cempra's innovative oral and intravenous next-generation fluoroketolide exhibiting high potency against respiratory pathogens, including drug-resistant strains, and broad spectrum activity against other serious pathogens. The oral form is ... read more
Solar EnerTech Corp. (OTCQB :SOEN) (the "Company") today announced that the Company's stock trades on the OTCQB, a marketplace developed by the OTC Markets Group, under the ticker symbol SOEN.
The Company is making this announcement because certain market makers have ceased using the OTC Bulletin Board (OTCBB) in favor of the OTCQB and when the number of market makers using the OTCBB falls to a single market maker the OTCBB ceases to provide a quotation. This is now the ... read more